As COVID-19 vaccine and treatment rollouts go global, people are eager to protect themselves against the virus and return to normal life. However, the extreme disparity between vaccine supply and demand creates an environment ripe for corruption. We’ve already seen groups in positions of power around the world seeking (and sometimes obtaining) preferential vaccine treatment, causing frustration and scandal. As vaccines and treatments are disseminated globally, it is crucial for in-house legal and compliance personnel to take steps to mitigate the anti-bribery & corruption risks that may accompany the manufacturing, distribution, and administration of these products, especially in high risk jurisdictions. With so many people desperate for vaccine doses and treatments, companies involved with global distribution should ensure their business strategies do not run afoul of the Foreign Corrupt Practices Act, the UK Bribery Act, and/or other applicable law.
To read more, please click here to view the full COVID-19 Vaccine Global Rollout and Associated Corruption Risks FAQ.
Click here for our COVID-19 vaccines updates.